Related Experiment Videos
Hepatitis E
E E Mast1, M A Purdy, K Krawczynski
1Hepatitis Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Bailliere'S Clinical Gastroenterology
|July 1, 1996
Summary
Hepatitis E virus (HEV) infection causes significant illness and death globally, especially in pregnant women. Research is advancing diagnostics and vaccines, but more study is needed on HEV transmission and immunity for effective prevention.
Area of Science:
- Hepatology
- Virology
- Epidemiology
Background:
- Hepatitis E virus (HEV) is a global pathogen causing significant disease burden, particularly in developing nations.
- HEV disproportionately affects pregnant women, leading to high morbidity and mortality.
- Recent advancements include HEV cloning, sequencing, and the development of new diagnostic tools.
Purpose of the Study:
- To characterize the natural history and epidemiological features of HEV infection using newly developed diagnostic tests.
- To explore the potential of experimental vaccines for preventing hepatitis E.
- To identify knowledge gaps regarding HEV transmission, reservoirs, and protective immunity.
Main Methods:
- Utilizing newly developed diagnostic tests to study HEV infection.
- Characterizing epidemiological features and natural history of the disease.
- Developing and evaluating experimental vaccines against HEV.
Main Results:
- New diagnostic tests have enabled initial characterization of HEV's natural history and epidemiology.
- Experimental vaccines show potential for preventing hepatitis E.
- Significant knowledge gaps persist regarding transmission, reservoirs, and immunity.
Conclusions:
- While progress has been made in understanding and combating HEV, further research is crucial.
- Effective prevention strategies require a deeper understanding of HEV transmission dynamics, viral reservoirs, and the long-term protective immunity.
- Continued research into HEV is essential for global public health, particularly in high-risk populations.